免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Catheter Ablation Using a Novel Navigation and Imaging System

NCT:NCT06895187 · NOT_YET_RECRUITING

NCT IDNCT06895187
狀態NOT_YET_RECRUITING
開始日期2027-01-01
完成時間2027-12-01
SponsorLUMA Vision Ltd. (INDUSTRY)
First posted
Last updated

簡要摘要

The objective of the ENVIsIoN study is to collect data on the use of the VERAFEYE navigation and imaging system in patients indicated to undergo a catheter ablation procedure for the treatment of Paroxysmal Atrial Fibrillation (PAF).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑